AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04866433 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Music
Description: Play the same music in both ears through headphones during sedation
Study NCT04866433 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Control
Description: Just wear headphones during sedation
Study NCT05004311 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cenerimod
Description: A single oral dose of 0.5 mg cenerimod will be administered as a film-coated tablet in the morning of Day 1 under fasted conditions
Study NCT04107077 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Laparoscopic HIPEC will be performed at a maximum of two (2) times spaced approximately 6 weeks apart. The dosing of the drugs will be the same during each administration but adjusted if needed based on lab work. The typical dosages are 200mg of Cisplatin
Study NCT04107077 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitomycin
Description: Laparoscopic HIPEC will be performed at a maximum of two (2) times spaced approximately 6 weeks apart. The dosing of the drugs will be the same during each administration but adjusted if needed based on lab work. The typical dosages are 30mg of Mitomycin C.
Study NCT06208800 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blend Aromatherapy
Description: Inhalation of a mixture of essential oils of peppermint, palmarosa for 10 minutes at 11:00 am during the day and vetiver, cedar, clary sage, musk sage, grapefruit and petitgrain for 10 minutes at 21:30 pm before bedtime for 4 weeks
Study NCT05213325 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Evaluation of serum levels of IL-6 and IL-8
Description: Evaluation of serum levels of IL-6 and IL-8 by Luminex Assay (multiplexed ELISA kits)
Study NCT04932226 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: cloth mask
Description: Buff bandana double layer worn over nose and mouth
Study NCT04932226 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: surgical mask
Description: standard surgical mask
Study NCT04932226 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: FFP2 respirator
Description: filtering facepiece 2 respirator
Study NCT05649943 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: APA + ADT
Description: All participants will receive apalutamide 240 mg (4 x 60 mg) tablets orally once daily. Apalutamide is distributed in Italy under the trade name of Erleada® 60 mg.~All patients not undergoing surgical castration should also continue medical castration by taking a gonadotropin-releasing hormone (GnRHa) analogue during treatment.
Study NCT05649943 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Local Treatmetn RT or RP
Description: Patients who will undergo radiotherapy as a local treatment must be treated according to the following scheme:~External beam radiotherapy administered at 36 Gy in six consecutive weekly fractions of 6 Gy, or 55 Gy in 20 daily fractions of 2・75 Gy over 4 weeks.~Radiation therapy will be given with the patient supine and with a full bladder and an empty rectum. The planned target volume is prostate only, with an 8 mm margin posteriorly and a 10 mm margin elsewhere.~No RT on lymph nodes is foreseen. RT should begin 6 months after the first dose of apalutamide (+/- 2 weeks).~Radical prostatectomy should be performed 6 months after the first dose of apalutamide (+/- 2 weeks).
Study NCT05207904 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab, paclitaxel, Carboplatin
Description: Tislelizumab, 200mg administered intravenously (IV) on Day 1 of each 21-day cycle paclitaxel 175 mg/m2 administered intravenously (IV) on Day 1 of each 21-day cycle, 4-6cycle Carboplatin AUC 5 administered intravenously (IV) on Day 1 of each 21-day cycle, 4-6 cycle
Study NCT06354205 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Sliva Procalcitonin
Description: Sliva Procalcitonin vs Blood procalcitonin
Study NCT04610450 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HEARO
Description: Robotic system for otological procedures
Study NCT04610450 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: OTOPLAN
Description: Otological surgical planning software
Study NCT05071716 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifaximin SSD
Description: Rifaximin Solid Soluble Dispersion Immediate Release Twice Daily
Study NCT05071716 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo Twice Daily
Study NCT05106751 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Hyaluronic acid dermal filler
Description: Hyaluronic acid dermal filler used for facial volume or wrinkle correction
Study NCT05106751 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid dermal filler
Description: Hyaluronic acid dermal filler used for facial volume or wrinkle correction
Study NCT05191368 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT06267521 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Healthy Minds Program
Description: Participants will follow daily instructions from the Healthy Minds Program at home for four weeks, including guided meditation exercises.
Study NCT06267521 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sham Meditation Didactic Material
Description: Participants will listen to lessons from the Healthy Minds Program at home for four weeks, which will not include any actual meditation exercises.
Study NCT06267521 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham Stimulation in Lab
Description: On two nights each week during the four weeks of the intervention, participants will sleep in the lab and undergo sham TES-TI stimulation for approximately 10 hours per night
Study NCT06267521 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Stimulation in Lab
Description: Participants will sleep in the lab and undergo active TES-TI stimulation for approximately 10 hours per night.
Study NCT04623359 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: High resolution manometry
Description: High resolution manometry
Study NCT04623359 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High resolution manometry
Description: High resolution manometry
Study NCT05226247 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Spontaneous breathing trial
Description: To perform cardiac and lung echography before and during a spontaneous breathing trial
Study NCT04875598 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound assisted - Laparoscopy assisted Transversus Abdominis Plane Block
Description: Ultrasound assisted TAPB application will be applied by an anesthesiology and reanimation specialist and Laparoscopy assisted TAPB application will be applied by the surgeon performing the operation.
Study NCT04700878 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Internet-based compassion course for stress managemant
Description: A five week long, structured self-help program with weekly reports to, and feedback from a compassion-focused (CFT) therapist over the Internet. Includes traditional CFT-methods for stress-related problems.
Study NCT04700878 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: General Internet-based cognitive behavioural course for stress management
Description: A five week long, structured self-help program with weekly reports to, and feedback from a cognitive-behavioral (CBT) therapist over the Internet. Includes traditional CBT-methods for stress-related problems.
Study NCT04700878 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: General Internet-based cognitive behavioural course for stress management
Description: A five week long, structured self-help program with weekly reports to, and feedback from a cognitive-behavioral (CBT) therapist over the Internet. Includes traditional CBT-methods for stress-related problems.
Study NCT05500898 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP16001
Description: Tablets, Oral, multiple doses of DWP16001
Study NCT06267521 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MRI Scanner
Description: Imaging protocol will include: structural T1-weighted and T2-weighted images, resting-state functional MRI, task-based functional MRI, and multi-shell diffusion weighted MRI, total scan time will be approximately 2 hours
Study NCT05500898 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWC202204+DWC202205
Description: Tablets, Oral, multiple doses of DWC202204 and DWC202205 in combination
Study NCT06339125 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fall prevention algorithm
Description: Algorithm generates fall prevention alerts to nurses in real time, using evidenced based electronic health record information regarding changes in care that may suggest the need for additional fall prevention strategies
Study NCT06339125 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inspiren camera visualization
Description: The Inspiren computer camera visualization is an additional strategy for nurses to employ when there is a change in a patient's fall risk.
Study NCT04800874 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BBP-418
Description: BBP-418 is being developed for the treatment of patients with Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I) for which no approved therapy currently exists. It targets the molecular defect at the source by supplying excess substrate to the mutant enzyme thus boosting glycosylation of muscle α-dystroglycan. The BBP-418 drug product will be packaged in sachets and provided in a carton for in-clinic and at home use.
Study NCT05500898 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP16001+DWC202204+DWC202205
Description: Tablets, Oral, DWP16001 , multiple doses of DWC202204 and DWC202205 in combination
Study NCT06368323 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Choir singing
Description: The 12-week intervention will consist of 12 in-person choir-singing sessions (1 session/week, 1,5 h/session, total 18h) conducted by a choir master in addition to home training (3 x 30-minutes-sessions/week, total 18h). In total, participants will undergo the intervention for 3 hours/week for 12 weeks (i.e., 36 hours).
Study NCT06368323 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual care
Description: Rehabilitation services received by patients and social activities will be monitored and documented.
Study NCT06276452 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation
Description: Psychoeducation is the therapeutic management of illness through the increase of related knowledge, skills, and motivation.
Study NCT01224652 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Paclitaxel, 70 mg/m2 will be administered as an intravenous (IV) infusion over 1 hour on Days 1, 8 and 15 of a 28-day cycle
Study NCT01224652 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan
Description: irinotecan 150 mg/m2 will be administered as an intravenous (IV) infusion over 1 hour on Days 1 and 15 of a 28-day cycle
Study NCT04309565 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Transitions Clinic Network Primary Care
Description: Transitions Clinic Network (TCN)- participants in this arm will be referred to a TCN program for primary care and community Opioid Treatment Program (OTP). All TCN programs have the ability to prescribe buprenorphine and Extended-release naltrexone (XR-NTX) and assist with referrals to methadone. The primary features of the TCN include (1) primary care and onsite MOUD or referral to community treatment when indicated, (2) addressing social determinants of OUD and care coordination through a Community Health Worker (CHW), and (3) addressing the discrimination and stigma that exist based on incarceration.
Study NCT04309565 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Primary Care
Description: Those randomized to the standard primary care arm will be referred to primary care and community Opioid Treatment Program (OTP). Participants may receive buprenorphine or Extended-release naltrexone (XR-NTX) through primary care or with a community addiction treatment provider.
Study NCT06536088 — intervention group
Intervention type: OTHER
Intervention: Walking assesment
Description: Spatiotemporal walking assessments are performed using the Gait Analyzer app (version 0.9.95.0) on a smartphone. Participants who can walk independently without assistance walk a 25-meter path at their normal speed, with the smartphone securely attached to their body above the third lumbar vertebra using a belt. The app records gait velocity, cadence, step time, step length, and vertical center of mass for all participants.
Study NCT06308757 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Very-low-calorie ketogenic diet (VLCKD) with meal replacements
Description: The VLCKD study arm will receive an experimental diet therapy with very-low-calorie ketogenic meal replacements (VLCKD) consisting of 5 successive phases (600 - 1500 kcal/day).
Study NCT06308757 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Mediterranean low-calorie diet (LCD)
Description: The Control arm LCD will receive standard Mediterranean type low-calorie diet (LCD) therapy by the most recent guidelines on MAFLD/NAFLD (1200-1500 kcal/day).
Study NCT06323317 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multi-component exercise programme
Description: Each exercise session will start with a warm-up, followed by core exercise training and ending with a cool-down period. A series of flexibility training and stretching exercises will be performed during the warm-up and cool-down phases (10 minutes in total). The core exercise session will comprise aerobic (10 minutes), resistance (20 minutes), and balance (20 minutes) training, where resistance and balance exercises constitute the major components, as they are particularly effective in strengthening functional capacity, muscle strength, and balance function for mobility in frail patients.
Study NCT06323317 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Attention Placebo
Description: The control group will receive routine preoperative care provided by the clinical team, which includes unstructured patient education on the surgeries/procedures, and a brief session on the use of an incentive spirometer, breathing, and coughing exercise. Other perioperative care procedures will be implemented according to the existing clinical protocols.
Study NCT06323317 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Structured preoperative education
Description: The prehabilitation programme will begin with a 60-minute (group- or individual-based) structured education session at the centre. The content will cover frailty, its impacts on postoperative recovery, cardiovascular and overall health, and functional well-being. The importance of nutrition and exercise on their recovery potential and postoperative functional capacity will be elaborated. Their commitment to intervention engagement will be highlighted as the key to success. This session will also cover the principles of exercise, its progression, and exercise safety.
Study NCT06323317 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutritional optimization
Description: The Malnutrition Universal Screening Tool (MUST) will be used for a nutritional screening to determine the risk of malnutrition (low, medium, or high). The nurse will evaluate the dietary patterns of each participant, and provide tailored nutritional advice on daily protein intake according to a protein supplementation protocol. The participants and their caregivers will be provided with plenty of suggestions for high-quality protein foods according to patients' preferences. The nurse will follow-up with the participants to identify any barriers they encountered in real-world settings when they attend the exercise sessions. She will reinforce the advice and provide suggestions to overcome barriers according to the preference and lifestyle of the participants.
Study NCT06323317 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stress management
Description: Relaxation techniques to reduce tense arousal, including guide imagery and breathing techniques, will be taught. Guided imagery makes use of attention-focus to target mental arousal, whereas deep and diaphragmatic breathing is a fundamental relaxation method for various stress relieving techniques. Both techniques are designed to reduce sympathetic arousal, which is particularly beneficial to cardiac patients. Participants will be encouraged to self-practice on a daily basis, and a sound track will be provided to guide their practice.
Study NCT06301009 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: AI-CAC score
Description: Deep-learning based prediction of the coronary artery calcium score with a plain chest x-ray
Study NCT05580328 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hematoporphyrin Injection actived by photodynamic therapy combined with Sonodynamic Therapy
Description: Hematoporphyrin in tumor tissue will be greatly enhanced by the combination of Sonodynamic Therapy and Photodynamic Therapy and achieve better treatment effect.
Study NCT05306522 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Spinal stabilization exercise
Description: The effects of telerehabilitation based spinal stabilization exercise in chronic stroke patients will be investigated.
Study NCT04719130 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multimodal circuit exercise
Description: A structured and supervised multimodal exercise circuit twice a week, under 12 weeks program. The circuit workout program consists of 8 exercises, divided into motor coordination, balance, strength, and aerobic exercises. The exercises will be employed in a reserved room inside of the Basic Health Units. The sessions of exercises will last approximately 50 minutes,
Study NCT04719130 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Multidisciplinary lectures
Description: Multidisciplinary lectures on pain and usual care provided by the Basic Health Units. A cycle of multidisciplinary lectures on pain will be offered by professionals in physical education, nursing, physiotherapy, medicine, psychology and social work that will take place in the Basic Health Units every 15 days.
Study NCT06125340 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 5 days of placebo to be given after 3-5 days of antibiotics
Study NCT06125340 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amoxicillin
Description: Standard-dose amoxicillin (approved by Health Canada) to be given x 5 days.
Study NCT06436755 — intervention group
Intervention type: PROCEDURE
Intervention: no intervention,this is a observational studies
Description: no intervention,this is a observational studies
Study NCT06433934 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Oxy2mask
Description: Open design oxygen mask
Study NCT05216458 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emails and letter intervention
Description: Emails and letters for households assigned to the treatment group
Study NCT05216458 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control group
Description: No outreach during the intervention period.
Study NCT05800496 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: SesZen-Bio™
Description: mode of usage: 1 capsule in the morning and 1 capsule at night. administration: Oral Administration
Study NCT05800496 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Mode of Usage: 1 capsule in the morning and 1 capsule at night. Route of Administration: Oral Administration
Study NCT04737005 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Nano-ceramic hybrid (Grandio Blocs) Endo-crown
Description: Nano-ceramic hybrid
Study NCT04737005 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Nano-ceramic hybrid (Grandio Blocs) Endo-crown
Description: Nano-ceramic hybrid
Study NCT05238363 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HLX07
Description: HLX07 1500mg ivgtt Q3W
Study NCT06118177 — intervention group
Intervention type: PROCEDURE
Intervention: connective tissue harvesting
Description: The subepithelial connective tissue graft was obtained in each patient using the single incision technique from the region between the mesial of canine and the mesial of first molar in the palate. Connective tissue dimensions were approximately 10 × 5 × 2 mm. Finally, the incision line was sutured with 5/0 synthetic, nonabsorbable, sterile monofilament suture
Study NCT06118177 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: ultrasonography
Description: A 6-18 MHz intraoral probe was used in intraoral USG examinations. Sterile gel was applied to the intraoral probe and covered with a stretch film. Then, it was placed directly on the mucosal surface of the donor site in the palatal area. Mucosal thickness was evaluated using the B-mode of the device, and vascularization was evaluated using the color doppler and pulsed wave doppler modes of the device. The following equation is used and calculated by US unit: Pulsality index (PI) = (Vmax-Vmin)/(Vmean) (Vmax is peak systolic flow velocity, Vmin is diastolic flow velocity and Vmean is mean flow velocity). The mean PI values of each patient were measured.
Study NCT06118177 — intervention group
Intervention type: OTHER
Intervention: autolog platelet rich fibrin application
Description: Leukocyte rich PRF (L-PRF) was obtained with the centrifugation of the two tubes at 2800 rpm for 12 minutes. After centrifugation, L-PRF clots were taken from the tubes using sterile tweezers, separated from the red blood cell base using scissors. Then L-PRF membrane was placed into the donor site.
Study NCT05352971 — intervention group
Intervention type: OTHER
Intervention: Biomarker quantification
Description: Patient blood samples will be tested on 2 different platforms